Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Septicemia | Case Report

A fatal case of neonatal viral sepsis caused by human parainfluenza virus type 3

Authors: Xiangpeng Chen, Hong Wang, Qi Li, Yujie Qi, Fei Li, Wenwen He, Qiushi Wang, Fei Jin, Yanqing Guo, Mingyan Hei, Zhengde Xie

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

Sepsis is a systemic inflammatory response syndrome caused by severe infection in children, but cases of sepsis associated with human parainfluenza virus (HPIV) have been rarely reported in newborns.

Case presentation

We report a case of HPIV-3 positive full-term newborn admitted to the Neonatal Intensive Care Unit of Beijing Children’s Hospital due to hematuria, gloomy spirit, inactivity and loss of appetite for 6 h. He had septic shock when he arrived the Accident & Emergency Department requiring immediate intubation and mechanical ventilation. Intravenous antibiotics were started. He had completely negative response to all anti-shock treatments including fluid resuscitation and vasopressor supports, and died 14 h later. Viral nucleic acid detection and metagenomic next-generation sequencing (mNGS) analyses of nasopharyngeal aspirate and blood specimens verified an HPIV-3 infection, with negative bacterial culture results. The HPIV-3 strain detected in this patient was subtyped as HPIV C3a, and two unreported amino acid mutations were found in the HN protein region.

Conclusion

The patient had a severe infection associated with HPIV-3, which was the cause of sepsis and septic shock. This study showed the diagnostic value of mNGS in etiological diagnosis, especially in severe neonatal case.
Literature
8.
go back to reference Abedi GR, Prill MM, Langley GE, Wikswo ME, Weinberg GA, Curns AT, et al. Estimates of Parainfluenza Virus-Associated Hospitalizations and cost among children aged Less Than 5 years in the United States, 1998–2010. J Pediatr Infect Dis Soc. 2016;5(1):7–13. https://doi.org/10.1093/jpids/piu047. Abedi GR, Prill MM, Langley GE, Wikswo ME, Weinberg GA, Curns AT, et al. Estimates of Parainfluenza Virus-Associated Hospitalizations and cost among children aged Less Than 5 years in the United States, 1998–2010. J Pediatr Infect Dis Soc. 2016;5(1):7–13. https://​doi.​org/​10.​1093/​jpids/​piu047.
17.
go back to reference Iorio RM, Field GM, Sauvron JM, Mirza AM, Deng R, Mahon PJ, et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J Virol. 2001;75(4):1918–27. https://doi.org/10.1128/jvi.75.4.1918-1927.2001. Iorio RM, Field GM, Sauvron JM, Mirza AM, Deng R, Mahon PJ, et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J Virol. 2001;75(4):1918–27. https://​doi.​org/​10.​1128/​jvi.​75.​4.​1918-1927.​2001.
20.
go back to reference Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis. 1997;175(4):807–13. https://doi.org/10.1086/513975. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis. 1997;175(4):807–13. https://​doi.​org/​10.​1086/​513975.
21.
25.
go back to reference Bloom HJK, Jacobsen R. Recovery of parainfluenza viruses from adults with upper respiratory tract illnesses. Am J Epi. 1961;74:50–9.CrossRef Bloom HJK, Jacobsen R. Recovery of parainfluenza viruses from adults with upper respiratory tract illnesses. Am J Epi. 1961;74:50–9.CrossRef
30.
go back to reference Phillips MJ, Blendis LM, Poucell S, offterson J, Petric M, Roberts E, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med. 1991;324(7):455–60. https://doi.org/10.1056/nejm199102143240705. Phillips MJ, Blendis LM, Poucell S, offterson J, Petric M, Roberts E, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med. 1991;324(7):455–60. https://​doi.​org/​10.​1056/​nejm199102143240​705.
32.
go back to reference Ueda K, Robbins DA, Iitaka K, Linnemann CC. Jr. Fatal rhabdomyolysis associated with parainfluenza type 3 infection. Hiroshima J Med Sci. 1978;27(2):99–103.PubMed Ueda K, Robbins DA, Iitaka K, Linnemann CC. Jr. Fatal rhabdomyolysis associated with parainfluenza type 3 infection. Hiroshima J Med Sci. 1978;27(2):99–103.PubMed
33.
go back to reference O’Connor JV, Iyer SK. Myoglobinuria associated with parainfluenza type 2 infection. N Y State J Med. 1982;82(10):1469–70.PubMed O’Connor JV, Iyer SK. Myoglobinuria associated with parainfluenza type 2 infection. N Y State J Med. 1982;82(10):1469–70.PubMed
35.
go back to reference Triana-Baltzer GB, Sanders RL, Hedlund M, Jensen KA, Aschenbrenner LM, Larson JL, et al. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. J Antimicrob Chemother. 2011;66(1):15–28. https://doi.org/10.1093/jac/dkq387. Triana-Baltzer GB, Sanders RL, Hedlund M, Jensen KA, Aschenbrenner LM, Larson JL, et al. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. J Antimicrob Chemother. 2011;66(1):15–28. https://​doi.​org/​10.​1093/​jac/​dkq387.
36.
go back to reference Chen YB, Driscoll JP, McAfee SL, Spitzer TR, Rosenberg ES, Sanders R, et al. Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation. Clin Infect Dis. 2011;53(7):e77–80. https://doi.org/10.1093/cid/cir501. Chen YB, Driscoll JP, McAfee SL, Spitzer TR, Rosenberg ES, Sanders R, et al. Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation. Clin Infect Dis. 2011;53(7):e77–80. https://​doi.​org/​10.​1093/​cid/​cir501.
37.
38.
go back to reference Watanabe M, Mishin VP, Brown SA, Russell CJ, Boyd K, Babu YS, et al. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice. Antimicrob Agents Chemother. 2009;53(9):3942–51. https://doi.org/10.1128/aac.00220-09. Watanabe M, Mishin VP, Brown SA, Russell CJ, Boyd K, Babu YS, et al. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice. Antimicrob Agents Chemother. 2009;53(9):3942–51. https://​doi.​org/​10.​1128/​aac.​00220-09.
39.
go back to reference Alymova IV, Watanabe M, Boyd KL, Chand P, Babu YS, Portner A. Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation. Antivir Ther. 2009;14(7):891–8. https://doi.org/10.3851/imp1420. Alymova IV, Watanabe M, Boyd KL, Chand P, Babu YS, Portner A. Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation. Antivir Ther. 2009;14(7):891–8. https://​doi.​org/​10.​3851/​imp1420.
40.
42.
go back to reference Elizaga J, Olavarria E, Apperley J, Goldman J, Ward K. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis. 2001;32(3):413–8. https://doi.org/10.1086/318498. Elizaga J, Olavarria E, Apperley J, Goldman J, Ward K. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis. 2001;32(3):413–8. https://​doi.​org/​10.​1086/​318498.
Metadata
Title
A fatal case of neonatal viral sepsis caused by human parainfluenza virus type 3
Authors
Xiangpeng Chen
Hong Wang
Qi Li
Yujie Qi
Fei Li
Wenwen He
Qiushi Wang
Fei Jin
Yanqing Guo
Mingyan Hei
Zhengde Xie
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02141-9

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.